The Breast Journal

Wiley

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

The Breast Journal is an open-access journal published by Wiley in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE according to the sources read. Declared publication charge: 2,580 USD. Declared review time at DOAJ: 19 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Wiley
ISSN
1075-122X · 1524-4741
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,580 USD
Articles in DOAJ
177
Declared review time
19 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2022-09-19
  • MEDLINE · 2001-01-01
Indexing
DOAJ · MEDLINE
APC
2,580 USD
Declared review time (DOAJ)
19 weeks
Actual review time (measured)
228 days received→accepted — computed from PubMed (n=100)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

177

Most recent article

last month

Average review time (journal-declared via DOAJ)

19weeks

Works in OpenAlex

4900

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

101

i10-index

1846

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-03-12
Added to DOAJ
2022-09-19
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
PMCPorticoCLOCKSS
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
93%
ORCID iDs in current deposits
93%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9505539
Classification4

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogensMedicine: Public aspects of medicine

LCC codes

RC254-282RA1-1270

Subject areas

  • Breast Lesions and Carcinomas
  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Breast Cancer Treatment Studies
  • Breast Lesions and Carcinomas
  • Breast Lesions and Carcinomas
  • Breast Implant and Reconstruction
  • Breast Implant and Reconstruction
Show all subjects (75)
  • Breast Implant and Reconstruction
  • Cancer and Skin Lesions
  • Cancer and Skin Lesions
  • Global Cancer Incidence and Screening
  • Global Cancer Incidence and Screening
  • MRI in cancer diagnosis
  • Digital Radiography and Breast Imaging
  • BRCA gene mutations in cancer
  • BRCA gene mutations in cancer
  • BRCA gene mutations in cancer
  • Global Cancer Incidence and Screening
  • Women's cancer prevention and management
  • Metastasis and carcinoma case studies
  • AI in cancer detection
  • Cancer Risks and Factors
  • Cancer Risks and Factors
  • Male Breast Health Studies
  • HER2/EGFR in Cancer Research
  • HER2/EGFR in Cancer Research
  • Reconstructive Surgery and Microvascular Techniques
  • Cancer Risks and Factors
  • Reconstructive Surgery and Microvascular Techniques
  • Cancer Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
  • Cancer and Skin Lesions
  • MRI in cancer diagnosis
  • MRI in cancer diagnosis
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Cancer survivorship and care
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • AI in cancer detection
  • AI in cancer detection
  • Salivary Gland Tumors Diagnosis and Treatment
  • Salivary Gland Tumors Diagnosis and Treatment
  • Estrogen and related hormone effects
  • Cancer survivorship and care
  • Cancer survivorship and care
  • Medical Imaging Techniques and Applications
  • Medical Imaging Techniques and Applications
  • Soft tissue tumor case studies
  • Sarcoma Diagnosis and Treatment
  • Soft tissue tumor case studies
  • Male Breast Health Studies
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • Estrogen and related hormone effects
  • Estrogen and related hormone effects
  • Male Breast Health Studies
  • HER2/EGFR in Cancer Research
  • Endometrial and Cervical Cancer Treatments
  • Metastasis and carcinoma case studies
  • Digital Radiography and Breast Imaging
  • Metastasis and carcinoma case studies
  • Reconstructive Surgery and Microvascular Techniques
  • Digital Radiography and Breast Imaging
  • Colorectal Cancer Screening and Detection
  • Colorectal Cancer Screening and Detection
  • Multiple and Secondary Primary Cancers
  • Cancer Treatment and Pharmacology
  • Soft tissue tumor case studies
  • Advanced Radiotherapy Techniques
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Gastric Cancer Management and Outcomes
  • Patient-Provider Communication in Healthcare

Keywords (DOAJ)

  • oncology
  • breast cancer
  • women’s health
  • public health

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: